Approved regimen
Approved labeled regimen
Product-, indication-, and jurisdiction-specific — see the monograph
- Russian OTC regimen: 10 mg orally, 2–3 times daily (20–30 mg/day). Typical course 1.5–3 months.
Dose evidence detail — Noopept
Detailed dose evidence documented for Noopept in its monograph — reference only, not dosing recommendations.
Reference only — not a dosing recommendation.
Studied in trials
Studied regimens (not recommendations)
Studied in trials — not a recommended dose
- Clinical studies used 5–20 mg/day orally for 28–90 days. No parenteral studies in humans.
- No established or recommended human dose.
Not established
What is not established
- Efficacy for any specific disease indication (AD, TBI, stroke)
- Long-term safety beyond 3 months
- Comparative effectiveness vs other nootropics
- Dose-response relationship
- Safety and efficacy of chronic use
Noopept — sección de dosis y administración de la monografía